I'm curious about a couple things

[ShiftyCapone]

So, i've been searching around on other boards more often lately and I have noticed that a lot of opinions on PCT are different elsewhere. Granted, most of the boards I have been frequenting are directed mostly towards AAS, so that could be the answer right there. But I'm not sure, so i'm asking here. A lot of people recommend Clomid over Nolva (and hardly ever mention Tore) during PCT. Its a pretty common consensus that Nolva definitely has its place, but thats more along the lines of battling gyno. So is that more of an AAS thing? Or is it just a difference of opinions amongst boards?

[Massivehunt]

Like I stated previously. I think serms like clomid and nolvadex are used way too much. Personally I think Gaspari's novedex xt and 6-oxo worked better for me than any of those. In addition, nolvadex is said to be hepatoxic to the liver. As I am no expert here, but lest see here. I run a 3-5 week methylated ph cycle then run a 3 week cycle of nolvadex. When does my liver get a break? However I do not know the hepatoxicity level of this drug. But as I was saying, it seems to me to be used too much. With the over the counter products we have right now inlcuding topical formestane, what is the problem in deviating away from serms. Furthermore, I thought ATD products were superior for pct? Maybe Im wrong. Also the problem I have with Nolvadex is that it only blocks estrogen receptors, allowing circulating estrogen to continue to exist.

[dinoiii]

Clomid is likely one of the few things to actually offer precipitous change to HPTA function (despite the copious tallies of posts and non-blood work promoted recommendations). Torem is no different than Tamoxifen in that it does NOT offer adequate HPTA recovery, though it does harbor a better "safety" profile (hence, the "in" thing to do on some boards is boast about the glories of this compound, which are too unfounded).

If looking collectively at PCT agents from this drug mechanistic action, it is likely prudent to view them in the following order out of the current crop of recommendations:

Clomid++ > Raloxifene+ >> Torem- > Nolva-

Where the greater the notion = the greater the efficacy to side-effect profile and the "+" and "-" designation in regards to HPTA recovery. Of course, concurrent low-dose hCG administration while on cycle avoids a lot of this discrepency.


D_

[usf97j4x4]

Clomid is likely one of the few things to actually offer precipitous change to HPTA function (despite the copious tallies of posts and non-blood work promoted recommendations). Torem is no different than Tamoxifen in that it does NOT offer adequate HPTA recovery, though it does harbor a better "safety" profile (hence, the "in" thing to do on some boards is boast about the glories of this compound, which are too unfounded).

If looking collectively at PCT agents from this drug mechanistic action, it is likely prudent to view them in the following order out of the current crop of recommendations:

Clomid++ > Raloxifene+ >> Torem- > Nolva-

Where the greater the notion = the greater the efficacy to side-effect profile and the "+" and "-" designation in regards to HPTA recovery. Of course, concurrent low-dose hCG administration while on cycle avoids a lot of this discrepency.


D_

D - the current attitude on this and some other boards is that nolva is more effective in treating/preventing gyno... is this accurate?

I have used both clomid and nolva on a PCT and I felt MUCH better on the clomid and also was back to being "myself" in less time.